Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Kidney Int. 2018 Oct 2;94(6):1189–1198. doi: 10.1016/j.kint.2018.06.024

Figure 4: Allograft survival in patients stratified by donor race and APOL1 genotype.

Figure 4:

Kaplan–Meier survival curves for post-biopsy cumulative kidney allograft survival in patients stratified as receiving grafts from AA donors with APOL1 high-risk genotypes, AA donors with APOL1 low-risk genotypes, and Caucasian donors (P=0.03)

AA donors/APOL1 high-risk genotypes vs. AA donors/APOL1 low-risk genotypes (P=0.029)

AA donors/APOL1 high-risk genotypes vs. Caucasian donors (P=0.026)

AA donors/APOL1 low-risk genotypes vs. Caucasian donors (P=0.76)